Biotech Startups

A company that developed a proprietary platform for single-cell immune profiling from small plasma volumes to enable non-invasive diagnostics. Founded from University of Zurich research, it applies immunology and data science to clinical diagnostics.

1 investor

Evoke Pharma develops treatments for gastrointestinal disorders, focusing on advancing and commercializing GIMOTI, a nasal spray formulation for diabetic gastroparesis. The company operates in the pharmaceutical and specialty care industry.

1 investor

Evolutionary Genomics applies genomic analysis and molecular selection detection to advance research in animal science, oncology, and infectious disease therapeutics. The company develops algorithms and research programs for identifying genetic targets and understanding molecular-level evolutionary processes.

1 investor

EvolutionaryScale develops artificial intelligence models for biology, including ESM3, a family of models that reason over protein sequence, structure, and function to help scientists understand and design novel proteins. Its models are offered to the scientific community through an API and partner platforms, with a smaller open model available under a non-commercial license.

1 investor

Evolved by Nature develops Activated Silk®, a biotech platform that extracts and engineers novel molecules from natural silk using its proprietary NoviCulture process to create biobased alternatives for applications in skincare, coatings, and materials. The company targets brands and manufacturers seeking sustainable, renewable replacements for petrochemical-derived ingredients and synthetic materials.

1 investor

Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

1 investor

Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.

1 investor

Excel Venture Management is a venture capital firm that invests in healthcare and life sciences companies across various sectors and stages, with a focus on businesses that lower costs and improve outcomes.

1 investor

Excite Pharma is an FDA-inspected, GMP/GLP-compliant contract research and manufacturing organization providing CMC services to pharmaceutical companies, with a focus on aseptic manufacturing and analytical chemistry across drug substance, drug product, and excipients. Its services span small-scale development, clinical and commercial manufacturing, method development and validation, stability programs, release testing, dissolution, residual solvent and metal analysis, and extractables and leachables testing.

1 investor

Exciting Instruments builds the EI-FLEX benchtop platform, a single-molecule fluorescence instrument combining smFRET, FCS and FCCS to measure biomolecular interactions and dynamics directly in solution. It serves academic and industry researchers in life science research, drug development, and clinical diagnostics.

1 investor

Exela Pharma Sciences operates cGMP-compliant contract development and manufacturing organization (CDMO) and fill-finish facilities producing injectable pharmaceuticals including vials, pre-filled syringes, and IV bags. The company serves pharmaceutical manufacturers seeking US-based contract manufacturing and development services.

1 investor

Exelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.

1 investor

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.

1 investor

ExoFlare builds a biosecurity platform designed to help intensive animal and food production operations manage disease risks and maintain market access during livestock disease events.

1 investor

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

Exolvo Biosciences develops drug delivery technology. The page does not provide sufficient detail about the company's specific products, markets served, or business model beyond the co-founder's background.

1 investor

Exonic develops machine learning models trained on biological data to predict gene therapy designs and genomic regulatory patterns, with initial applications in developing targeted treatments for liver cancer.

1 investor

Exosomm is a biotechnology company that extracts and standardizes bioactive milk exosomes into commercial ingredients for advanced nutrition and supplement brands. The company licenses these bioactive compounds as a differentiated platform for premium health and wellness products.

1 investor

1 investor

Expedition Therapeutics is a drug development company focused on advancing therapeutic programs in areas such as CAR-T immunotherapy and oncology. The company serves patients and healthcare systems seeking novel treatment options.

1 investor

Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services. The company provides process development, analytical testing, technology transfer, and scale-up support for inhalation drugs and encapsulated solid dose pharmaceuticals.

1 investor

ExploraMed is a medical device incubator that develops new med tech companies and products from early-stage concept through development. Its portfolio includes ventures such as Revelle Aesthetics, an aesthetics medical device company acquired by Tiger Aesthetics in 2024.

1 investor

Exposome researches how environmental factors affect human health and develops products through its formulations and application lab, supported by its own manufacturing facility. The company operates in the health and wellness space with in-house product development and production.

1 investor

Exprimary develops bioanalytical instrumentation and assay products at reduced cost for research and diagnostic markets. The company focuses on enabling personalized healthcare by improving access to bioanalysis tools globally.

1 investor